These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39010313)

  • 21. Head to head comparison of [
    Jang YK; Lyoo CH; Park S; Oh SJ; Cho H; Oh M; Ryu YH; Choi JY; Rabinovici GD; Kim HJ; Moon SH; Jang H; Lee JS; Jagust WJ; Na DL; Kim JS; Seo SW
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):432-442. PubMed ID: 29143870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cognitive chameleon: lessons from a novel MAPT mutation case.
    Liang Y; Gordon E; Rohrer J; Downey L; de Silva R; Jäger HR; Nicholas J; Modat M; Cardoso MJ; Mahoney C; Warren J; Rossor M; Fox N; Caine D
    Neurocase; 2014; 20(6):684-94. PubMed ID: 23998300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral hypometabolism and grey matter density in MAPT intron 10 +3 mutation carriers.
    Deters KD; Risacher SL; Farlow MR; Unverzagt FW; Kareken DA; Hutchins GD; Yoder KK; Murrell JR; Spina S; Epperson F; Gao S; Saykin AJ; Ghetti B
    Am J Neurodegener Dis; 2014; 3(3):103-14. PubMed ID: 25628962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation.
    Lindquist SG; Holm IE; Schwartz M; Law I; Stokholm J; Batbayli M; Waldemar G; Nielsen JE
    Eur J Neurol; 2008 Apr; 15(4):377-85. PubMed ID: 18284428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and neuroimaging characterization of the first frontotemporal dementia family carrying the MAPT p.K298E mutation.
    Pozzi FE; Aprea V; Giovannelli G; Lattuada F; Crivellaro C; Bertola F; Castelnovo V; Canu E; Filippi M; Appollonio I; Ferrarese C; Agosta F; Tremolizzo L
    Neurogenetics; 2024 Jul; 25(3):215-223. PubMed ID: 38592608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapidly Progressive Frontotemporal Dementia Associated with MAPT Mutation G389R.
    Sun L; Chen K; Li X; Xiao S
    J Alzheimers Dis; 2017; 55(2):777-785. PubMed ID: 27802239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales.
    Fumagalli GG; Basilico P; Arighi A; Bocchetta M; Dick KM; Cash DM; Harding S; Mercurio M; Fenoglio C; Pietroboni AM; Ghezzi L; van Swieten J; Borroni B; de Mendonça A; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni GB; Laforce R; Finger E; Sorbi S; Scarpini E; Rohrer JD; Galimberti D;
    Alzheimers Res Ther; 2018 May; 10(1):46. PubMed ID: 29793546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
    Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
    Mol Psychiatry; 2018 Jul; 23(7):1666-1673. PubMed ID: 28507319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation.
    Morino H; Kurashige T; Matsuda Y; Ono M; Sahara N; Miyasaka T; Soeda Y; Shimada H; Yamazaki Y; Takahashi T; Izumi Y; Ito H; Maruyama H; Higuchi M; Arihiro K; Suhara T; Takashima A; Kawakami H
    Mov Disord Clin Pract; 2024 Jun; 11(6):720-727. PubMed ID: 38605589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [
    Lagarde J; Olivieri P; Caillé F; Gervais P; Baron JC; Bottlaender M; Sarazin M
    J Neurol; 2019 Dec; 266(12):3087-3097. PubMed ID: 31535269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [
    Santillo AF; Leuzy A; Honer M; Landqvist Waldö M; Tideman P; Harper L; Ohlsson T; Moes S; Giannini L; Jögi J; Groot C; Ossenkoppele R; Strandberg O; van Swieten J; Smith R; Hansson O
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1371-1383. PubMed ID: 36513817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vivo
    Tang Y; Li L; Hu T; Jiao F; Han L; Li S; Xu Z; Fan Y; Sun Y; Liu F; Yen TC; Zuo C; Wang J
    Mov Disord; 2023 Jan; 38(1):147-152. PubMed ID: 36368769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury.
    Mitsis EM; Riggio S; Kostakoglu L; Dickstein DL; Machac J; Delman B; Goldstein M; Jennings D; D'Antonio E; Martin J; Naidich TP; Aloysi A; Fernandez C; Seibyl J; DeKosky ST; Elder GA; Marek K; Gordon W; Hof PR; Sano M; Gandy S
    Transl Psychiatry; 2014 Sep; 4(9):e441. PubMed ID: 25226550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a P301L mutation in microtubule-associated protein tau (MAPT).
    Rasmussen MA; Hjermind LE; Hasholt LF; Waldemar G; Nielsen JE; Clausen C; Hyttel P; Holst B
    Stem Cell Res; 2016 Jan; 16(1):70-4. PubMed ID: 27345788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
    Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
    Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A heterozygous splicing variant IVS9-7A > T in intron 9 of the MAPT gene in a patient with right-temporal variant frontotemporal dementia with atypical 4 repeat tauopathy.
    Mori K; Shigenobu K; Beck G; Uozumi R; Satake Y; Suzuki M; Kondo S; Gotoh S; Yonenobu Y; Kawai M; Suzuki Y; Saito Y; Morii E; Hasegawa M; Mochizuki H; Murayama S; Ikeda M
    Acta Neuropathol Commun; 2023 Aug; 11(1):130. PubMed ID: 37563653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier.
    Bevan-Jones WR; Cope TE; Jones PS; Passamonti L; Hong YT; Fryer T; Arnold R; Coles JP; Aigbirhio FI; O'Brien JT; Rowe JB
    Ann Clin Transl Neurol; 2019 Feb; 6(2):373-378. PubMed ID: 30847369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MAPT Q336H mutation: Intrafamilial phenotypic heterogeneity in a new Italian family.
    Villa C; Rossi G; Bizzozero I; Prioni S; Boiocchi C; Agosta F; Canu E; Filippi M; Giaccone G; Caroppo P
    Eur J Neurol; 2022 May; 29(5):1529-1533. PubMed ID: 35020237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.